Clinical Trials Browser

OTHER × Carcinoma, Hepatocellular × Cetuximab × Clear all

NCT00483405 2017-07-12

NRR

Phase 2 Completed

33 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00142428 2014-03-18

Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular